International trade · 21/09/1994Updated: 10/18/2026 · 1 min read
Teva Pharmaceuticals Designates Additional Investigative Attorney for Diltiazem Hydrochloride and Diltiazem Preparations Investigation
Summary
Teva Pharmaceuticals has designated an additional attorney to lead the investigation into Certain Diltiazem Hydrochloride and Diltiazem Preparations, a matter currently under review by the US FDA
Original source language: Federal Register — International Trade CommissionOpen original release →